Keyphrases
Inhalation
100%
Lipid-polymer Hybrid Nanoparticles
100%
Spray Drying
100%
Small Interfering RNA (siRNA)
100%
Mannitol
50%
Critical Quality Attributes
50%
Optimal Operating
50%
Operating Space
50%
Solid Dosage Form
50%
RNA Therapeutics
25%
Colloidal Stability
25%
Stabilizing Excipients
25%
Hybrid Nanoparticles
25%
Nanomedicine
25%
Total Solid Content
25%
Solid Formulation
25%
Low Water Content
25%
Poly(D,L-lactic-co-glycolic acid)
25%
Release Profile
25%
Design of Experiments
25%
Quality by Design
25%
RNA Release
25%
Scale-up Production
25%
Nanoparticles
25%
Size Ratio
25%
Physicochemical Characteristics
25%
Mass Median Aerodynamic Diameter
25%
Powder Particle Size
25%
Gene Silencing
25%
Loading Ratio
25%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Small Interfering RNA
100%
Dosage Form
50%
Mannitol
50%
Nanomedicine
25%
Solid Formulation
25%
Glycolic Acid
25%
Excipient
25%